April 16th 2025
RenovoCath is designed to deliver diagnostic and therapeutic agents directly to targeted tissues, offering a localized approach to treatment that can minimize systemic exposure.
The HELM Life Sciences Cluster created to accelerate global health care innovation
April 9th 2025
She replaces Tom Westrick, who is retiring after 20 years